SGS SA (SWX:SGSN) acquired Quay Pharmaceuticals Ltd on December 6, 2021. The turnover of Quay Pharma for the year ended May 31, 2021 was approximately CHF 21 million. 200 highly skilled scientists and technicians joined SGS's Health Science group and the current management team will continue to lead the business.

SGS SA (SWX:SGSN) completed the acquisition of Quay Pharmaceuticals Ltd on December 6, 2021.